Mark Chin

Mark has 15 years of healthcare experience across venture capital, strategy consulting, business and corporate development. Prior to joining Avoro Ventures, Mark was a Managing Director at Arix Bioscience focused on private and public biotech investments. During his time at Arix, he sourced and led 10 private biotech investments resulting in 4 IPOs, 2 reverse mergers, and 2 acquisitions. Prior to Arix, Mark was a Principal at Longitude Capital, where he focused on investments in biotechnology and medical technology companies. Prior to Longitude, he was a consultant at the Boston Consulting Group and worked in corporate development at Gilead Sciences and market planning at Genentech.